Oct 13 (Reuters) - Immuron Ltd (IMC) :
- IMMURON STRATEGIC INVESTMENT IN LEADING GUT HEALTH BIOTECH ATERIA HEALTH
- IMMURON SAYS INTENTION TO ENTER INTO RECIPROCAL DISTRIBUTION AGREEMENT FOR TRAVELAN® IN U.K. MARKET AND JUVIA™ IN AUSTRALIAN AND NORTH AMERICAN MARKETS
- UPFRONT CASH INVESTMENT OF £1.48M FUNDED FROM IMMURON'S EXISTING CASH RESERVES
- NET PROCEEDS WILL BE USED BY ATERIA FOR PRODUCT LAUNCH AND ONGOING PRODUCT MARKETING OF JUVIA
- NET PROCEEDS WILL BE USED BY ATERIA RESEARCH AND DEVELOPMENT (FURTHER CLINICAL TRIALS) FOR JUVIA PRODUCTS
News: IMC Immuron Strategic Investment In Leading Gut Health Biotech Ateria Health
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.8M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.3¢ | 10.0¢ | $37.90K | 379.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 39207 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 217757 | 9 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.0¢ | 9.9¢ | 166996 | ||
| Last updated 13.09pm 06/05/2024 ? | |||||
| IMC (ASX) Chart |